- Home
- CABA vs COE Comparison
CABA vs COE Comparison
Compare CABA & COE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- COE
- Stock Information
- Founded
- CABA 2017
- COE 2011
- Country
- CABA United States
- COE Singapore
- Employees
- CABA N/A
- COE N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- COE Other Consumer Services
- Sector
- CABA Health Care
- COE Real Estate
- Exchange
- CABA Nasdaq
- COE Nasdaq
- Market Cap
- CABA 118.8M
- COE 115.0M
- IPO Year
- CABA 2019
- COE 2016
- Fundamental
- Price
- CABA $2.06
- COE $19.78
- Analyst Decision
- CABA Strong Buy
- COE
- Analyst Count
- CABA 8
- COE 0
- Target Price
- CABA $26.13
- COE N/A
- AVG Volume (30 Days)
- CABA 1.4M
- COE 19.2K
- Earning Date
- CABA 03-20-2025
- COE 03-21-2025
- Dividend Yield
- CABA N/A
- COE N/A
- EPS Growth
- CABA N/A
- COE N/A
- EPS
- CABA N/A
- COE N/A
- Revenue
- CABA N/A
- COE $41,924,000.00
- Revenue This Year
- CABA N/A
- COE N/A
- Revenue Next Year
- CABA N/A
- COE N/A
- P/E Ratio
- CABA N/A
- COE N/A
- Revenue Growth
- CABA N/A
- COE 69.79
- 52 Week Low
- CABA $1.76
- COE $6.00
- 52 Week High
- CABA $24.85
- COE $25.70
- Technical
- Relative Strength Index (RSI)
- CABA 38.28
- COE 45.81
- Support Level
- CABA $2.03
- COE $19.55
- Resistance Level
- CABA $2.90
- COE $25.70
- Average True Range (ATR)
- CABA 0.24
- COE 1.57
- MACD
- CABA -0.04
- COE -0.34
- Stochastic Oscillator
- CABA 4.00
- COE 8.36
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.
About COE 51Talk Online Education Group
51 Talk Online Education Group is an online education platform in China, with core expertise in English education. The company's mission is to make quality education accessible and affordable. It's online and mobile education platforms enable students across China to take live interactive English lessons with overseas foreign teachers, on demand.